|
|
|
|
| LEADER |
03930nmm a2200289 u 4500 |
| 001 |
EB000285729 |
| 003 |
EBX01000000000000000049963 |
| 005 |
00000000000000.0 |
| 007 |
cr||||||||||||||||||||| |
| 008 |
090727 ||| eng |
| 020 |
|
|
|a 9781592595952
|
| 050 |
|
4 |
|a QH573-671
|
| 100 |
1 |
|
|a Scanlon, Kevin J.
|e [editor]
|
| 245 |
0 |
0 |
|a Therapeutic Applications of Ribozymes
|h Elektronische Ressource
|c edited by Kevin J. Scanlon
|
| 250 |
|
|
|a 1st ed. 1998
|
| 260 |
|
|
|a Totowa, NJ
|b Humana Press
|c 1998, 1998
|
| 300 |
|
|
|a XIV, 462 p
|b online resource
|
| 505 |
0 |
|
|a Small Efficient Hammerhead Ribozymes -- The Hairpin Ribozyme -- Molecular Manipulations of the Catalytic RNAs from the Human Hepatitis Delta Virus -- The Design, Production, and Validation of an Anti-HIV Type 1 Ribozyme -- Methods for Treating HIV by Gene Therapy Using Ribozymes -- An Expression Vector for Multiple Ribozymes -- Viral RNA Targets for Ribozymes -- Hammerhead Ribozyme-Mediated Cleavage of Hepatitis B Virus RNA -- Bovine Leukemia Virus Ribozymes -- Use of Ribozymes to Specifically Alter the MDR-1 Phenotype -- Adenoviral-Mediated Anti-H-ras Ribozyme for the Treatment of Bladder Cancer -- Tissue-Specific Delivery of an anti-H-ras Ribozyme Against Malignant Melanoma -- Ribozymes as a Novel Approach for the Treatment of Human Pancreatic carcinoma -- K-rasRibozyme for Lung Cancer -- Anti-c-erb-B-2 Ribozyme for Breast Cancer -- Ribozymes -- Preformed Ribozymes -- Folate-Polylysine-Mediated Delivery of a Multiunit Anti-BCR/ABL Ribozyme to BCR/ABL-Transformed 32D Cells -- Ribozymes Targeted Against AML1/MTG8 -- Ribozyme Targeting of the Growth Factor Pleiotrophin -- Ribozyme-Mediated Inhibition of Cell Proliferation -- Inhibition of ?APP Synthesis by Ribozymes and Oligonucleotides in a Coupled Reticulocyte Transcription Translation System -- Selective Modification of Fatty Acid Synthesis Pathway by Expression of an Acetyl-CoA Carboxylase-Specific Ribozyme Gene -- In Vivo Knockout of a Tissue-Specific Gene by Synthetic Ribozymes -- Ribozyme-Mediated Downregulation of Gene Expression in Transgenic Mice -- Targeted Cleavage of RNA Using External Guide Sequences and Eukaryotic RNase P -- Application of In Vitro Selection in Design of External Guide Sequences That Direct Efficient Cleavage of RNA by RNase P -- A PCR-Based Approach to Hammerhead Ribozyme Synthesis -- Measurement of Ribozyme Activity Using RNase Protection
|
| 653 |
|
|
|a Cell Biology
|
| 653 |
|
|
|a Cytology
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b SPRPROT
|a Springer Protocols Archive 1981-2004
|
| 490 |
0 |
|
|a Methods in Molecular Medicine
|
| 024 |
8 |
|
|a 10.1385/0896034771
|
| 856 |
4 |
0 |
|u https://doi.org/10.1385/0896034771?nosfx=y
|x Verlag
|3 Volltext
|
| 082 |
0 |
|
|a 571.6
|
| 520 |
|
|
|a In Therapeutic Applications of Ribozymes, expert laboratory scientists describe in detail their methodologies for constructing ribozymes designed to elucidate the role of specific genes as key routes to the development of novel therapies for a wide variety of diseases. The authors review the many sites targeted with ribozymes in various diseases and provide specific accounts of the practical techniques required for the proper use of ribozymes in these systems. Their cutting-edge protocols demonstrate how to achieve ribozyme expression in distinct cellular systems, the preparation and use of high-efficiency ribozyme DNA or RNA delivery, and the studies required to prove the efficacy of ribozyme-mediated inhibition, with its concomitant effect on phenotypic parameters. Therapeutic Applications of Ribozymes contains all the practical detail necessary to realize the high promise of ribozyme technology as a significant, widely used methodology. Focused on ribozyme targets and the novel associated technology, the book immediately becomes the leading resource for all those seeking to transform this new category of therapeutic agent into efficacious clinical practice
|